Objective: To study the influence of esophageal cancer surgeon volume upon mortality from upper gastrointestinal emergencies. Background: Volume-outcome relationships led to the centralization of esophageal cancer surgery. Methods: Hospital Episode Statistics data were used to identify patients admitted to hospitals within England (1997England ( -2012. The influence of esophageal high-volume (HV) cancer surgeon status (!5 resections per year) upon 30-day and 90-day mortality from esophageal perforation (EP), paraesophageal hernia causing obstruction or gangrene (PEH) and perforated peptic ulcer (PPU) was analyzed, independent of HV esophageal cancer center status and patient and disease-specific confounding factors. Results: A total of 3707, 12,411, and 57,164 patients with EP, PEH, and PPU, respectively, were included. The observed 90-day mortality was 36.5%, 11.5%, and 29.0% for EP, PEH, and PPU, respectively. Management by HV cancer surgeon was independently associated with significant reductions in 30-day and 90-day mortality from EP (odds ratio, OR 0.51, 95% confidence interval, CI, 0.40-0.66), PEH (OR¼0.70, 95% CI 0.53-0.91), and PPU (OR¼0.85, 95% CI 0.7-0.95). Subset analysis of those patients receiving primary surgery as treatment showed no change in mortality when performed by HV cancer surgeons. However HV cancer surgeons performed surgery as primary treatment more commonly for EP (OR¼2.38, 95% CI 1.87-3.04) and PEH (OR¼2.12, 95% CI 1.79-2.51). Furthermore surgery was independently associated with reduced mortality for all 3 conditions. Conclusion: The complex elective workload of HV esophageal cancer surgeons appears to lower the threshold for surgical intervention in specific upper gastrointestinal emergencies such as EP and PEH, which in turn reduces mortality.
I
n England since 2001, after a national policy recommendation, there has been a consistent shift toward the centralization of esophagogastric cancer resections to high-volume (HV) centers, which has led to consistent reduction in perioperative mortality. [1] [2] [3] [4] The national audit of England and Wales, demonstrates a reduction in esophagectomy inhospital mortality from 4.5% (2007) (2008) (2009) to 1.9% (2013-2015) . 5 There have been several publications illustrating the importance of hospital volume in reducing postoperative mortality from esophagectomy. 6, 7 However studies, which have directly compared surgeon and hospital volume, assign greater importance to surgeon volume in improving prognosis from esophagectomy. 8, 9 There is a paucity of evidence concerning the effect of health system related factors upon mortality from emergency upper gastrointestinal conditions. Surgery remains the primary treatment in most cases for these emergency conditions; however, the threshold for utilization of surgery may vary among surgeons. One driver to increase the utilization of surgery, as emergency treatment may be an increase in the complexity of the elective workload as reflected by an increase in esophageal cancer resections.
The hypothesis under investigation is that management of complex emergency upper gastrointestinal conditions by HV esophageal cancer surgeons is associated with reduced mortality.
To test this hypothesis, 3 different benign emergency upper gastrointestinal conditions were studied:
1. Esophageal perforation (EP); complex condition with low incidence. 2. Obstructed or gangrenous paraesophageal hernia (PEH); complex condition with average incidence. 3. Perforated peptic ulcer (PPU); less complex condition with high incidence.
METHODS
Data were derived from the Hospital Episode Statistics (HES) database. 10 This is a record-based system that collects patientlevel data from all National Health Service (NHS) hospitals in England. It captures all patients treated in public sector hospitals and a minor of patients treated in privately funded institutions. Patients are given a unique HES identifier that allows all of their hospital admissions to be tracked throughout the dataset. The HES dataset is a well-validated dataset and has been used in several previous publications concerning esophageal cancer 11, 12 and emergency gastrointestinal conditions. 13, 14 Permissions for the comparison of anonymized administrative data were obtained from the National Information Governance Board for Health and Social Care in England.
From the

Coding of Data
Relevant International Classification of Disease 10th revision (ICD-10) codes were used to identify patients over the age of 17 years who were admitted as an emergency for the treatment of: (1) EP (K22.3), (2) obstructed or gangrenous PEH (K44.0 and K44.1), or (3) PPU (K25.1, K25.2, K25.5, K25.6, K26.1, K26.2, K26.5, K26.6, K27.1, K27.2, K27.5, and K27.6), between January 1, 1997 and December 31, 2012 and were included in the study. Only patients identified as emergency admissions were included in this analysis using the admission codes (method of admission 21-28). Patients transferred between hospitals (admission codes 28 and 81) were classified based upon the hospital where they received the primary surgical intervention, and in the absence of any intervention they were classified based upon the hospital they were discharged from. Treatments were identified using the Office of Population Censuses and Surveys Classification of Surgical Operations and Procedures 4th revision (OPCS-4) codes (Appendix A, http://links.lww.com/ SLA/B277).
Exposure
The exposure under investigation was the effect of elective surgeon esophageal cancer volume upon mortality from EP, PEH, and PPU. The total and average elective annual volume of esophageal cancers operated on by individual surgeons during the study period was calculated. Only esophagectomy for esophageal cancer 11, 12 was included and other cases such as gastrointestinal stromal tumor wedge resections and staging laparoscopies were excluded. Surgeons were divided based upon an average annual esophageal cancer threshold of 5 per year into low and highvolume surgeons, as this was the 90th centile for the esophagectomy cohort.
Outcomes
The outcomes were 30-day and 90-day mortality, which was identified by linking HES data with data from the Office for National Statistics (ONS). The process of data linkage was performed centrally using a unique patient National Health Service (NHS) number, which permits linkage of data between patient datasets. Local Institutional Review Board ethics was obtained for this study.
Statistical Analysis
Statistical analysis was performed using SPSS version 22.0 software (Statistical Package for the Social Sciences software, Version 22, SPSS Chicago, IL).
Categorical variables are expressed as a percentage, with intergroup comparisons made using x 2 test. Multivariable logistic regression analyses were performed to evaluate the positive or negative association of HV cancer surgeon's status (!5 per year) with 30-day and 90-day mortality from EP, PEH, and PPU. Three regression models were constructed for the analysis: All analyses were performed for all patients and subset analyses for patients who received primary surgery. All statistical tests were 2-sided, with the threshold of significance set at a P < 0.05.
RESULTS
Population Characteristics
From 1997 to 2012, in total 3707, 12,441, and 57,164 patients were admitted as an emergency with EP, obstructed or gangrenous paraesophageal hernia and PPU respectively. Table 1 describes the patient demographics in all patients and those patients that received primary surgery in all three conditions. Across all 3 conditions the proportion of patients aged !70 years and with Charlson Comorbidity Index score !2 was lower in patients receiving surgery compared with all patients. In addition, the proportion of patients with markers of disease severity being esophageal cancer (EP), presence of gangrene (PEH), and gastric or duodenal cancer (PPU) were lower in the surgery group. The 30-day mortality was 28.5%, 7.0%, and Surgery was utilized as primary treatment in 15.5%, 12.8%, and 55.9% of patients with EP, PEH, and PPU respectively. Across all 3 conditions, surgery was associated with an absolute reductions in 30-day and specifically in 90-day mortality of 13.3% (relative risk change, RRC ¼ À49%) for EP, 1.5% (RRC ¼ À40%) for PEH, and 8.6% (RRC ¼ À20%) for PPU (Table 1) . Multivariable regression analyses for the confounding variables described in model 1, also identified surgery was associated with significant reductions in 30-day mortality, for EP (odds ratio, OR¼0.57, 95% confidence interval, CI, 0.44-0.72), for PEH (OR¼0.86, 95% CI 0.71-0.99), and for PPU (OR¼0.50, 95% CI 0.48-0.53). A similar beneficial effect of surgical intervention was observed with 90-day mortality, for EP (OR¼0.60, 95% CI 0.48-0.76), for PEH (OR¼0.80, 95% CI 0.64-0.99), and for PPU (OR¼0.51, 95% CI 0.48-0.53).
The Eeffect of HV Cancer Surgeon Status
Esophageal Perforation (EP)
HV cancer surgeons utilized surgery as the primary treatment approach more commonly (28.8% vs 13.8%; P<0.001) ( Table 2 ). This increase in surgery by HV surgeons was confirmed in multivariable regression analyses after controlling for patient and disease confounding variables, HV cancer center status, and HV emergency condition status (OR¼2.60, 95% CI 2.04-3.30) ( Table 3) .
There was an absolute reduction in 30-day and 90-day mortality of 10.8% [29.7%-18.9% (RRC ¼ À36.4%) and 11.6% (37.8%-26.2% (RRC ¼ À30.7%); P<0.001] respectively, associated with management by HV cancer surgeons (Table 2) . Multivariable regression analyses with control for confounders described in models (1, 2, and 3 demonstrated in all patients, management by HV cancer surgeons was associated with a reduction in 30-day (OR¼0.51, 95% CI 0.39-0.67) and 90-day mortality (OR¼0.52, 95% CI 0.41-0.68) ( Table 4 ). However in the surgery group, HV cancer surgeon status did not affect 30-day (OR¼1.14, 95% CI 0.66-1.98) or 90-day (OR¼0.87, 95% CI 0.53-1.45) mortality in univariate or multivariable analyses. There were also no differences in operative approach between HV and LV esophageal cancer surgeons ( Table 2 ).
Obstructed or Gangrenous Paraesophageal Hernia (PEH)
HV cancer surgeons increased the utilization of surgery as treatment for PEH by 12.4% (11.9%-24.3%; P<0.001) ( Table 2 ). This increase in surgical treatment by HV cancer surgeons was confirmed in multivariable analysis ( (Table 2) .
Perforated Peptic Ulcer (PPU)
There was no difference between HV and LV cancer surgeons in the utilization of surgery as treatment for PPU in univariate (Table 2) or multivariable analyses (Table 3) . In univariate analysis, in all PPU patients, management by HV cancer surgeons was associated with a significant reduction in 90-day mortality [26.0% vs 24.0% (RRC ¼ À7.7%), P¼0.043] ( Table 2 ). In multivariable analysis management by HV surgeon remained an independent predictor of reduced 30-day (OR¼0.88, 95% CI 0.78-0.99) and 90-day mortality (OR¼0.85, 95% CI 0.76-0.96) ( Table 4 ). Similar to the other 2 conditions, when subset analysis of PPU patients receiving surgery was performed HV cancer surgeon status failed to influence 30-day (OR¼0.99, 95% CI 0.83-1.18) or 90-day mortality (OR¼0.95, 95% CI 0.81-1.13). There were also no differences in operative approach between HV and LV esophageal cancer surgeons (Table 2) .
DISCUSSION
Management by HV esophageal cancer surgeons reduced 30-day and 90-day mortality cross all 3 emergency upper gastrointestinal conditions for all patients. However, the relative risk reduction in 90-day mortality for the more complex lower incidence conditions (EP and PEH) was around 30%, but for PPU, although statistically significant, was only minimal at 8%. Surgery as primary management was an independent predictor of reduced mortality in both EP (RRC ¼ À49%) and POH (RRR¼ À40%) and management by HV cancer surgeons was associated with an increase in the utilization of surgery. Importantly when subset analysis of only those patients receiving surgery was performed, HV cancer surgeon status failed to influence mortality, and there were no differences in operative approaches between the groups. Putting these findings together, for EP and PEH it appears that HV esophageal cancer surgeons utilize surgery more commonly as primary management and this in turn is associated with a reduction in mortality.
The limitations of this type of population based cohort study must be acknowledged in the interpretation of these results. First, it was not possible to define patient physiological status on admission, severity, or degree of contamination from perforation or degree of Models: HV surgeons !5 per year esophageal cancer resections over the study period.
(1) Adjusted for age (<70 or !70), sex (male or female), Charlson Comorbidity Index (<2 or !2) and for EP -Esophageal Cancer (Yes or No), for PEH -PEH gangrene (yes or no), and for PPU -gastric or duodenal cancer (yes or no).
(2) Adjusted for age (<70 or !70), sex (male or female), Charlson Comorbidity Index (<2 or !2), HV cancer center (<20 or !20 esophago-gastric cancer resections per year) and for EP -Esophageal Cancer (Yes or No), PEH -PEH gangrene (yes or no), and for PPU -gastric or duodenal cancer (yes or no).
(3) Adjusted for age (<70 or !70), sex (male or female), Charlson Comorbidity Index (<2 or !2), HV emergency center (<5 or !5 admissions per year for EP, <11 or !11 admissions per year for PEH, <23.1 or !23.2 admissions per year for PPU) and for EP -Esophageal Cancer (Yes or No), for PEH -PEH gangrene (yes or no), and for PPU -gastric or duodenal cancer (yes or no).
CI indicates confidence interval; EP, esophageal perforation; HV, high volume; PEH, paraesophageal hernia; PPU, perforated peptic ulcer; OR, odds ratio. hernia ischemia, or other clinical drivers that may have influenced treatment allocation or affected clinical outcome. Second, administrative datasets such as HES do not provide data regarding cause of death, and the data presented are for all-cause mortality. As a large national database study the results generated are dependent upon the reliability of the methodology and accuracy of data collection, which is a limitation shared by all national administrative databases. It may be suggested that the infrastructure available at the hospitals may have influenced these results; however, we have controlled for HV cancer center status and for HV emergency admission status (for these conditions), with similar results demonstrated (Table 4) . Further in the classification of esophageal cancer surgeon volum,e all cancer cases operated on under the care of the named senior surgeon were included, and thus cases operated on by more junior supervised surgeons would have been classified under the senior surgeon. Despite these limitations, the population-based design with virtually complete inclusion of all eligible patients in England is strength of the study. The large sample size, complete follow up of all patients, and the adjustment for several relevant confounding factors are other advantages.
The results of this study suggest that a complex elective surgical workload as reflected by HV esophageal cancer surgeon status appears to lower the threshold for surgical intervention in complex emergency benign upper gastrointestinal conditions such as EP and PEH. Importantly, there was no difference in operative approach or mortality between HV and LV cancer surgeons when specifically looking at patients who received surgery, suggesting the operation is performed safely by both volume groups. However, there appears to be a difference in patient selection for surgical intervention, with HV cancer surgeons employing a more aggressive patient allocation to surgery for complex upper gastrointestinal emergencies. This parallels results in vascular surgery, with high elective abdominal aortic aneurysm practice leading to an increase in the proportion of ruptured aneurysm patients receiving surgical intervention and consequently improving survival. 15 For the relatively less common conditions, EP and PEH only 15.5% and 12.8% of patients received surgical intervention respectively and thus the increased utilization of surgery by HV cancer surgeons had a substantial effect and was associated with large risk reductions for mortality. However, for PPU with 55.9% of patients receiving surgery, with a much smaller risk reduction in mortality associated with management by HV cancer surgeons. This difference for PPU may be a reflection of the lower complexity and the more common prevalence of the condition.
Research conducted by our group has established the relationship between increasing emergency admission hospital volume and reduced mortality for EP and PEH. 13, 14 Furthermore, recently we have shown the HV cancer center status reduces mortality from EP. 16 Importantly within this current analysis for surgeon esophageal cancer volume, we controlled for both of these factors for all 3 conditions (Table 4) . The results of this study do parallel those seen for esophagectomy, with surgeon volume assuming greater prognostic importance than hospital volume. 8, 9 However, this is not because of improvements in surgical outcomes or performance, it is because of a lower threshold for utilization of surgical intervention associated with management by HV esophageal cancer surgeons for complex conditions, such as EP and PEH.
EP is a low incidence condition, and thus this study provides further evidence that this condition is best managed by HV cancer surgeons practicing within HV cancer centers. These surgeons are experienced with performing esophagectomy and thus have a lower threshold to employ surgical treatment. PEH is an average incidence condition, and although this study suggests an improved outcome when managed by HV cancer surgeons, centralization of this condition would be practically challenging. Furthermore, it must be acknowledged that there are noncancer surgeons who perform elective repair of complex giant paraesophageal hernias in high volumes, who are likely to have sufficient expertise to manage this condition safely in the emergency setting. PPU remains a common condition with our research to date suggesting no volume or cancer management benefit, and thus there is no rationale for centralization of such a condition.
In conclusion, this study suggests HV esophageal cancer surgeons with an electively complex workload have a lower threshold for surgical intervention in complex upper gastrointestinal emergencies such as EP and PEH, which in turn reduces mortality. This study provides further evidence for the need to centralize the management of EP to HV cancer centers with HV cancer surgeons, and sufficient expertise to manage this low incidence condition with a high attributable mortality.
article and the privilege of the floor. I would like also to thank Dr. Sheraz Markar for his nice presentation.
The aim of this population based cohort study is not to evaluate the impact of a surgeon's elective upper GI-cancer volume on POM in patients with acute upper GI-conditions, including EP, incarcerated hiatal hernia, perforated ulcer. Emergency admissions in England over a 16-year period were identified through the Hospital Episodes Statistics database, a nationwide database. Management by a high-volume surgeon (superior or equal to 5 resections for cancer per year) reduced 90-day POM from all these 3 conditions. However, patients undergoing primary surgical treatment had similar mortality when managed by high-or low-volume surgeons. The authors conclude that the HV surgeons' lower threshold for surgical intervention may be responsible for lower POM.
The topic is original, important, and up-to-date. The article is concise, the study based on a very large and unselected populationbased cohort, the statistical analysis is appropriate and the conclusions quite clear and practical for the future.
I have the following comments: First, outcomes were adjusted on age, comorbidity, cancer center status, and emergency center status. However, acute upper GIconditions considered, including EP, incarcerated hiatal hernia, and perforated ulcer, are broad terms that each comprises (i) a variety of pathological entities and (ii) with different degrees of severity.
Second, factors that were initially considered for each patient to choose for one treatment strategy versus another were wrong, not all included in the analysis, may be leading to some potential bias, or some potential variations in the magnitude of the effect (OR).
Third, I think that centralization should not be only considered on the center volume but also on the available resources whatever it could be meaning (i) skills (ii) technical equipment available. What are your thoughts on that point?
Fourth, the type of surgical intervention performed in highversus low-volume centers remains unclear with unspecified surgical interventions. In addition, an indefinite and probably very large cause of death (medically or surgically related) may have occurred. Consequently, it cannot be excluded that the results presented here just reflect a general referral pattern of surgical upper-GI emergency cases.
Fifth, more and more conservative approaches are nowadays considered for EPs. Do you agree with that and what are your thoughts about it?
Sixth, did authors looked at a linear positive impact on POM with increasing the number of esophageal cancer resection per year? Even if this might have an impact of underpowering the analysis, it may offer better chance to patients. What for you think on that point? Seventh, I understood that patients transferred between hospitals were classified based upon the hospital where they received the primary surgical intervention, and in the absence of any intervention they were classified upon the hospital they were discharged from. Do you have any interesting additional data on the consequence of such practices? Meaning impact of transfer (or not) on outcomes?
Eighth, from a statistical point of view, why not having used a propensity score matched analysis?
Again, I would to congratulate the authors for such piece of work and the opportunity to have a look on it.
Response From Sheraz Markar (London, UK):
I would like to thank Professor Mariette for his insightful comments regarding this article, and I reply to each question in turn.
First, I absolutely agree with you and I think that risk-adjustment of cases is a limitation of analyzing emergency conditions through administrative national data sets such as this. The thing that I would like to say is that the structure of our healthcare system in England is that we are a nationalized healthcare system so these emergency patients present to their local hospital in an unselected fashion. Therefore, there is no introduction or referral bias which may be the case with a cancer study for example.
Second, Table 3 describes the multi-variate analysis for utilization of surgery as the primary treatment approach, and included age, sex, Charlson Comorbidity Index and disease specific factors such as the presence of cancer for esophageal and peptic ulcer perforation and the presence of gangrene for obstructed paraesophageal hernia.
Third, unfortunately we do not have data within this national dataset pertaining to technical skills and equipment at each individual center; however, given the centralization of cancer care and funding which followed, we have used hospital cancer volume as a surrogate for this. With the hypothesis that an electively complex workload ensures a greater concentration of multi-disciplinary technical expertise within the center.
Fourth, within the revised article, in Table 2 we describe the specific surgical procedures performed with no significant differences among the groups. We describe 30-day and 90-day all-cause mortality with appropriate risk adjustment for medical morbidity, and thus we believe we are truly describing the burden of these conditions and a true change in mortality attributable from these conditions from management in HV cancer centers.
Fifth, I agree in England, interventional radiological and endoscopic management of EP particularly is a relatively controversial subject. Some centers in individual studies have suggested very good outcomes from these types of approaches. However, I do think what you will find if you start to look at this in detail, is that if you're an interventional radiologist or an interventional endoscopist with an electively complex workload, this is in parallel to what we've seen with cancer surgeons, who have an electively complex workload and their results will be better, so probably parallel to what I've shown here.
Sixth, I performed a linear correlation analysis as suggested; however, as you suspected this underpowered the analysis.
Seventh, I did look at this issue, and was able to show similar results between patients transferred to a HV cancer center to those who were primarily admitted to a HV cancer center, suggesting that transfer of selected patients may be a safe strategy for EP. However, these patients must be stable for transfer and thus represent a selected cohort.
Finally, we have previously used propensity-matched analysis based upon regression modeling in the past. Given the multiple comparisons made in this study, we felt for ease of understanding to the reader to present the results of the regression models with the appropriate risk adjustment as described.
Again, I would like to thank Professor Mariette for his valuable and insightful comments.
Peter A. Lodge (Leeds, UK):
Thank you, a nice presentation Sheraz. I just have 2 short questions: Do you think that your data is good enough to show a surgeon effect, and is this not a center effect? For instance, where I work in Leeds, half of the time on call it's a pancreatic or liver surgeon as opposed to an upper GI surgeon who would be dealing with these patients. Can you tell from your data, really that this is not just a hospital volume effect as opposed to a surgeon effect?
The second question is, you seem to show less effect with PPU so do you think that's because the majority of PPUs would be dealt with by the broad range of surgical trainees as opposed to a more specialist surgeon coming in?
